Insulin as a primary autoantigen for type 1A diabetes

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Type 1A diabetes mellitus results from autoimmune destruction of pancreatic beta cells.
• Other islet cell types (alpha, delta, PP) remain unaffected.
• Autoantigens are classified by tissue distribution: beta-cell-specific, neurendocrine, and ubiquitous.

Purpose of the Study:

• This review focuses on insulin as a primary autoantigen in Type 1A diabetes mellitus.
• Investigate the role of insulin and its peptides in disease pathogenesis.
• Explore the potential of insulin-based therapies for diabetes prevention.

Main Methods:

• Review of existing literature on insulin autoantigens in Type 1A diabetes.
• Analysis of studies involving insulin peptide B:9-23 in animal models.
• Examination of genetic studies on insulin gene polymorphisms and diabetes development.

Main Results:

• Insulin is a critical autoantigen in Type 1A diabetes.
• Immunization with insulin peptide B:9-23 can induce autoantibodies and diabetes in models, or prevent it.
• Insulin gene variations influence childhood diabetes susceptibility.

Conclusions:

• Insulin is a primary autoantigen in Type 1A diabetes.
• The pathogenesis is linked to the immune system's recognition of specific insulin peptides.
• Targeting insulin may offer therapeutic strategies for Type 1 diabetes.